184 related articles for article (PubMed ID: 6088881)
1. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
[TBL] [Abstract][Full Text] [Related]
2. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx.
Takimoto T; Sato H; Ogura H; Tanaka S; Umeda R
Laryngoscope; 1988 Dec; 98(12):1334-8. PubMed ID: 2849005
[TBL] [Abstract][Full Text] [Related]
3. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
[TBL] [Abstract][Full Text] [Related]
5. Further studies on growth characteristics of Epstein-Barr virus (EBV) genome-positive and -negative epithelial hybrid cell lines.
Takimoto T; Tanaka S; Ishikawa S; Masuda K; Umeda R
Laryngoscope; 1989 Jul; 99(7 Pt 1):741-3. PubMed ID: 2545984
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus lytic cycle spreads via cell fusion in a nasopharyngeal carcinoma hybrid cell line.
Yoshizaki T; Takimoto T; Takeshita H; Tanaka S; Furukawa M; Seiki M; Sato H
Laryngoscope; 1994 Jan; 104(1 Pt 1):91-4. PubMed ID: 8295464
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
[TBL] [Abstract][Full Text] [Related]
8. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
Takimoto T; Umeda R
Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
Takimoto T; Furukawa M; Hatano M; Umeda R
Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641
[TBL] [Abstract][Full Text] [Related]
11. [Demonstration of Epstein-Barr virus (EBV)-related antigens and tumorigenicity in nude mice in a hybrid cell line derived from the fusion of an EBV-positive lymphoblastoid cell and an EBV-negative epithelial cell from the human nasopharynx].
Ishiguro H
Nihon Jibiinkoka Gakkai Kaiho; 1984 Jun; 87(6):693-707. PubMed ID: 6092593
[No Abstract] [Full Text] [Related]
12. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
Seto E; Ooka T; Middeldorp J; Takada K
Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
Steplewski Z; Koprowski H; Andersson-Anvret M; Klein G
J Cell Physiol; 1978 Oct; 97(1):1-8. PubMed ID: 213442
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
17. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
Takimoto T; Sato H; Ogura H; Miyazaki T
Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
[TBL] [Abstract][Full Text] [Related]
18. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
Takimoto T; Sato H; Ogura H; Glaser R
Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of a novel cell line derived from nasopharyngeal carcinoma].
Yao KT
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):34-6. PubMed ID: 2364868
[TBL] [Abstract][Full Text] [Related]
20. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
